Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TR-701 FA vs linezolid in hospital-acquired/ventilator-associated pneumonia
CTR20140572Phase 3Completed
- Sponsor
- Trius Therapeutics
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tedizolid in hospital-acquired pneumonia (HAP), ventilator-associated pneumonia (VAP), Staphylococcus aureus infection, sponsored by Trius Therapeutics. Started Jan 2015; status: completed.
02
Drugs
tedizolid
03
Conditions
hospital-acquired pneumonia (HAP)ventilator-associated pneumonia (VAP)Staphylococcus aureus infection
Beyond the preview
Go deeper on CTR20140572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140572.